EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSEBUG00000006422
Gene Symbol: PSMD14
1 Cross references
215 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSEBUG00000004609
Gene Symbol: PSMD6
1 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSEBUG00000015451
Gene Symbol: PSMD7
1 Cross references
248 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSEBUG00000007224
Gene Symbol: PSMD8
1 Cross references
213 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSEBUG00000002328
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSEBUG00000014257
Gene Symbol: PRKCZ
1 Cross references
204 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSEBUG00000013178
Gene Symbol: PRKCDA
1 Cross references
283 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSEBUG00000015310
Gene Symbol: PPP3CA
1 Cross references
241 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSEBUG00000016968
Gene Symbol: PTPN11A
1 Cross references
253 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSEBUG00000011260
Gene Symbol: P2RY1
1 Cross references
191 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSEBUG00000005646
Gene Symbol: RAMP1
1 Cross references
252 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSEBUG00000002312
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).